Abbott Laboratories (ABT) Inventory Average (2009 - 2026)

Abbott Laboratories has disclosed Inventory Average across 18 years of filings, most recently posting $7.2 billion for Q2 2026.

• In Q2 2026, Inventory Average rose 5.23% year-over-year to $7.2 billion; the TTM figure through Jun 2026 stood at $7.2 billion (up 5.23% YoY), while the FY2025 annual figure was $6.3 billion, down 0.64% from the prior year.
• Inventory Average came in at $7.2 billion for Q2 2026 at Abbott Laboratories, up from $6.7 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $7.2 billion in Q2 2026 to a low of $5.4 billion in Q1 2022.
• Average Inventory Average over 5 years is $6.5 billion, with a median of $6.7 billion recorded in 2023.
• Year-over-year, Inventory Average climbed 18.42% in 2023 and fell 4.21% in 2025.
• Over 5 years, Inventory Average stood at $6.0 billion in 2022, then grew by 11.03% to $6.6 billion in 2023, then declined by 1.61% to $6.5 billion in 2024, then grew by 1.45% to $6.6 billion in 2025, then gained by 8.4% to $7.2 billion in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $7.2 billion in Q2 2026, $6.7 billion in Q1 2026, and $6.6 billion in Q4 2025.